Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bal Pharma's share price for the quarter that ended in Mar. 2026 was ₹60.14. Bal Pharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 16 Mil. Therefore, Bal Pharma's market cap for the quarter that ended in Mar. 2026 was ₹957 Mil.
Bal Pharma's quarterly market cap
declined
from Sep. 2025 (₹1,321 Mil) to Dec. 2025 (₹1,166 Mil) and
declined
from Dec. 2025 (₹1,166 Mil) to Mar. 2026 (₹957 Mil).
Bal Pharma's annual market cap
declined
from Mar. 2024 (₹1,442 Mil) to Mar. 2025 (₹1,324 Mil) and
declined
from Mar. 2025 (₹1,324 Mil) to Mar. 2026 (₹957 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bal Pharma's Enterprise Value for Today is ₹2,930 Mil.
Bal Pharma (BOM:524824) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bal Pharma Market Cap Related Terms
Bal Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for Bal Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bal Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bal Pharma Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bal Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Bal Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bal Pharma's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bal Pharma (BOM:524824) has a Market Cap of ₹1,444 Mil as of Jul. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bal Pharma and its competitors. According to the industry distribution chart, Bal Pharma ranks #841 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 82.3%.
Is Bal Pharma's Market Cap too high?
Bal Pharma's current Market Cap is ₹1,444 Mil. Based on the distribution chart, Bal Pharma ranks #841 out of 1022 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Bal Pharma has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bal Pharma's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Bal Pharma ranks #841 out of 1022 companies for Market Cap. This places Bal Pharma in the lower half of its industry. The industry median Market Cap is 220.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 220.60, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bal Pharma and its competitors. For the Drug Manufacturers industry, the median Market Cap is 220.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bal Pharma's current Market Cap is ₹1,444 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bal Pharma stock overvalued right now?
Based on GuruFocus' analysis, Bal Pharma (BOM:524824) is currently considered Fairly Valued. The stock's GF Value™ is ₹97.37, compared to a current price of ₹90.72 — trading 6.8% below its estimated fair value. The current Market Cap is ₹1,444 Mil. Bal Pharma's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bal Pharma (BOM:524824), the current Market Cap is ₹1,444 Mil as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bal Pharma (BOM:524824) Overvalued in 2026?
Based on GuruFocus' analysis, Bal Pharma stock appears to be undervalued.
The current stock price of ₹90.72 is trading 6.8% below its estimated GF Value™ of ₹97.37.
GuruFocus considers Bal Pharma to be Fairly Valued.
Key valuation signals for BOM:524824:
Market Cap: ₹1,444 Mil
GF Value™: ₹97.37 vs. price of ₹90.72 (6.8% below fair value)
No single metric tells the full story. See the BOM:524824 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives.
65GF Score
Get the complete analysis for BOM:524824
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524824 has been successfully added to your 
